PharmaCyte Biotech (PMCB) Gross Margin (2010 - 2012)
PharmaCyte Biotech (PMCB) posted quarterly Gross Margin of 53.01% for Q4 2012, down 12260.0% year-over-year from N/an in Q4 2011, and down 153.01% quarter-over-quarter from 100.0% in Q3 2012.
PharmaCyte Biotech (PMCB) Gross Margin (2010 - 2012) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported Gross Margin for 3 consecutive years, with 53.01% the latest figure, recorded in Q4 2012.
- In Q4 2012, Gross Margin fell 12260.0% year-over-year to 53.01%; the TTM figure through Jul 2013 stood at 53.01% (down 14607.0% YoY), while the FY2013 annual figure was 20.89%, down 4999.0% from the prior year.
- Gross Margin slipped to 53.01% in Q4 2012 per PMCB's latest filing, from 100.0% in the prior quarter.
- Across five years, Gross Margin topped out at 167.94% in Q2 2012 and bottomed at 53.01% in Q4 2012.
- Historically, Gross Margin has averaged 68.13% across 3 years, with a median of 78.16% in 2010.
- On a YoY basis, Gross Margin climbed as much as 7932 bps in 2012 and fell as far as 12260 bps in 2012.
- PharmaCyte Biotech's Gross Margin stood at 82.02% in 2010, then fell by 15 bps to 69.58% in 2011, then plunged by 176 bps to 53.01% in 2012.
- Business Quant data shows PMCB's Gross Margin at 53.01% in Q4 2012, 100.0% in Q3 2012, and 167.94% in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | - |
| 10 | PharmaCyte Biotech | 4.44 Mn | 4.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2012 | -53.01% |
| Jul 31, 2012 | 100.00% |
| Apr 30, 2012 | 167.94% |
| Jan 31, 2012 | 89.09% |
| Oct 31, 2011 | 69.58% |
| Jul 31, 2011 | 20.68% |
| Apr 30, 2011 | 99.33% |
| Jan 31, 2011 | 31.36% |
| Oct 31, 2010 | 82.02% |
| Jul 31, 2010 | 74.31% |